The pharmaco-economics of peri-operative beta-blocker and statin therapy in South Africa

South African Medical Journal

Volumn 96, Issue 11, 2006, Pages 1199-1202

  Biccard, Bruce M ^a,b   Sear, J W ^a   Foex P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL;

ACUTE HEPATITIS; ACUTE KIDNEY FAILURE; ARTICLE; BRADYCARDIA; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; COST CONTROL; DISEASE EXACERBATION; DRUG COST; ELECTIVE SURGERY; HEART ARREST; HEART DEATH; HEART INFARCTION; HUMAN; HYPOTENSION; LIVER FAILURE; MAJOR SURGERY; PERIOPERATIVE PERIOD; PROSPECTIVE STUDY; RHABDOMYOLYSIS; SOUTH AFRICA; STROKE; SUDDEN DEATH; UNSTABLE ANGINA PECTORIS; VALIDITY;

ADRENERGIC BETA-ANTAGONISTS; AGED; CARDIOVASCULAR DISEASES; COSTS AND COST ANALYSIS; ECONOMICS, PHARMACEUTICAL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTRAOPERATIVE COMPLICATIONS; MIDDLE AGED; PERIOPERATIVE CARE; SOUTH AFRICA;

EID: 33751355855     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Biccard BM, Sear JW, Foëx P. Stalin therapy: a potentially useful peri-operative intervention in patients with cardiovascular disease. Anaesthesia 2005; 60: 1106-1014.
2. Le Manach Y, Penel A, Coriat P Godet G, Bertrand M, Riou B. Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology 2005; 102: 885-891.
3. Biccard BM, Sear JW Foëx P. The pharmacoeconomics of peri-operative beta-blocker therapy Anaesthesia 2006; 61: 4-8.
4. Biccard BM Sear JW,Foëx P. The pharmaco-economics of peri-operative statin therapy. Anaesthesia 2005; 60: 1059-1063.
5. Bayliff CD, Massel DR, Inculet RI, et al. Propranolol for the prevention of postoperative arrhythrmias in general thoracic surgery. Ann Thorac Surg 1999; 67; 182-186.
6. Brady AR, Gibbs JS, Greenhalgh RM, Powell JT, Sydes MR. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 2005; 41: 602-609.
7. Jakobsen CJ, Bille S, Ahlburg F, Rybro U, Pedersen KD, Rasmussen B. Preoperative metoprolol improves cardiovascular stability and reduces oxygen consumption after thoracotomy Acta Anaesthesiol Scand 1997; 41: 1324-1330.
8. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341: 1789-1794.
9. Raby KE, Brull SJ, Timimi F, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 1999; 88: 477-482.
10. Urban MK, Markowitz SM, Gordon MA, Urquhart BL, Kligfield P. Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg 2000; 90: 1257-1261.
11. Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998; 88: 7-17.
12. Yang H, Raymer K, Butler R, Parlow J, Roberts R. Metoprolol after vascular surgery (MaVS). Can J Anaesth 2004; 51: A7.
13. Zaugg M, Tagliente T, Lucchinetti E, et al. Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 1999; 91: 1674-1686.
14. Schouten O, Kertai MD, Bax JJ, et al. Safety of perioperative statin use in high-risk patients undergoing major vascular surgery. Am J Cardiol 2005; 95: 658-660.
15. Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004; 39: 967-975; discussion 975-976.
16. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996; 335: 1713-1720.
17. Poldermans D, Boersma E, Bax JJ, et al. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 2001; 22: 1353-1358.
18. The POISE trial investigators. Rationale, design and organization of the PeriOperative ISchernic Evaluation (POISE) Trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. Am Heart 12006; 152: 223-230.
19. Discovery Health (Pty) Ltd South Africa. Private Health Insurer, administrative data. 2004.
20. Steyn K, Sliwa K, Hawken S, et al. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation 2005; 112: 3554-3561.
21. Ranjith N, Pegoraro RJ, Naidoo DP. Demographic data and outcome of acute coronary syndrome in the South African Asian Indian population. Cardiovascular Journal of South Africa 2005; 16: 48-54.
22. Joubert J, McLean CA, Reid CM, et al. Ischemic heart disease in black South African stroke patients. Stroke 2000; 31: 1294-1298.
23. Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 2005; 331: 313-321.
24. Boersma E, Poldermans D, Bax JJ, et al. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2001; 285:1865-1873.
25. Freemantle N, Cleland J, Young F, Mason J, Harrison J. Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999; 318: 1730-1737.